Compare ICCC & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICCC | DAVA |
|---|---|---|
| Founded | 1982 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.1M | 108.3M |
| IPO Year | 1995 | 2015 |
| Metric | ICCC | DAVA |
|---|---|---|
| Price | $10.32 | $1.68 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.68 |
| AVG Volume (30 Days) | 6.2K | ★ 238.3K |
| Earning Date | 11-12-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.85 | N/A |
| EPS | ★ 0.41 | N/A |
| Revenue | ★ $26,493,169.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.70 |
| P/E Ratio | $25.29 | ★ $20.02 |
| Revenue Growth | ★ 51.64 | N/A |
| 52 Week Low | $4.52 | $1.52 |
| 52 Week High | $12.10 | $9.47 |
| Indicator | ICCC | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 52.11 | 37.20 |
| Support Level | $9.45 | $1.60 |
| Resistance Level | $10.76 | $1.98 |
| Average True Range (ATR) | 0.22 | 0.13 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 48.80 | 26.21 |
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.